Korean J Pain.  2013 Jan;26(1):21-26. 10.3344/kjp.2013.26.1.21.

Survey on the Treatment of Postherpetic Neuralgia in Korea; Multicenter Study of 1,414 Patients

• Nahm FS
• Kim SH
• Kim HS
• Shin JW
• Yoo SH
• Yoon MH
• Lee DI
• Lee YW
• Lee JH
• Jeon YH
• Jo DH

• KMID: 1779019
• DOI: http://doi.org/10.3344/kjp.2013.26.1.21

Abstract

BACKGROUND
Postherpetic neuralgia (PHN) is a serious complication resulting from herpes zoster infections, and it can impair the quality of life. In order to relieve pain from PHN, various treatments, including pharmacological and interventional methods have been used. However, little information on the recommendations for the interventional treatment of PHN, along with a lack of nation-wide surveys on the current status of PHN treatment exists. This multicenter study is the first survey on the treatment status of PHN in Korea.
METHODS
Retrospective chart reviews were conducted on the entire patients who visited the pain clinics of 11 teaching hospitals from January to December of 2011. Co-morbid disease, affected site of PHN, routes to pain clinic visits, parenteral/topical medications for treatment, drugs used for nerve block, types and frequency of nerve blocks were investigated.
RESULTS
A total of 1,414 patients' medical records were reviewed. The most commonly affected site was the thoracic area. The anticonvulsants and interlaminar epidural blocks were the most frequently used pharmacological and interventional methods for PHN treatment. For the interval of epidural block, intervals of 5 or more-weeks were the most popular. The proportion of PHN patients who get information from the mass media or the internet was only 0.8%.The incidence of suspected zoster sine herpete was only 0.1%.
CONCLUSIONS
The treatment methods for PHN vary among hospitals. The establishment of treatment recommendation for PHN treatment is necessary. In addition, public relations activities are required in order to inform the patients of PHN treatments by pain clinicians.

Keyword

epidemiology; health care surveys; herpes zoster; postherpetic neuralgia; therapy

MeSH Terms

Anticonvulsants
Health Care Surveys
Herpes Zoster
Hospitals, Teaching
Humans
Incidence
Internet
Mass Media
Medical Records
Nerve Block
Neuralgia, Postherpetic
Pain Clinics
Public Relations
Quality of Life
Retrospective Studies
Zoster Sine Herpete
Anticonvulsants

Figure

• 

  Fig. 1 Affected site of postherpetic neuralgia. The most commonly affected site was thoracic area and followed by trigeminal area.

• 

  Fig. 2 Parenteral and topical medications used for PHN treatment. The most frequently used medication was anticonvulsants.

• 

  Fig. 3 Local anesthetics used for nerve blocks. Mepivacaine was the most frequently used.

• 

  Fig. 4 Distribution of nerve block intervals. (A) Epidural block, (B) sympathetic block, (C) peripheral block, (D) paravertebral block, and (E) cranial nerve block. There are 2 peaks in the distribution of each blocks.

Reference

1. Drolet M, Brisson M, Schmader KE, Levin MJ, Johnson R, Oxman MN, et al. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. CMAJ. 2010; 182:1731–1736. PMID: 20921251.

2. Gauthier A, Breuer J, Carrington D, Martin M, Rémy V. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect. 2009; 137:38–47. PMID: 18466661.

3. Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007; 82:1341–1349. PMID: 17976353.

4. Gialloreti LE, Merito M, Pezzotti P, Naldi L, Gatti A, Beillat M, et al. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis. 2010; 10:230. PMID: 20682044.

5. Sim WS, Choi JH, Han KR, Kim YC. Treatment of herpes zoster and postherpetic neuralgia. Korean J Pain. 2008; 21:93–105.

6. Argoff CE. Review of current guidelines on the care of postherpetic neuralgia. Postgrad Med. 2011; 123:134–142. PMID: 21904096.

7. Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007; 132:237–251. PMID: 17920770.

8. Manchikanti L, Boswell MV, Singh V, Benyamin RM, Fellows B, Abdi S, et al. ASIPP-IPM. Comprehensive evidence-based guidelines for interventional techniques in the management of chronic spinal pain. Pain Physician. 2009; 12:699–802. PMID: 19644537.

9. Baek IY, Park JY, Kim HJ, Yoon JU, Byoen GJ, Kim KH. Spinal cord stimulation in the treatment of postherpetic neuralgia in patients with chronic kidney disease: a case series and review of the literature. Korean J Pain. 2011; 24:154–157. PMID: 21935494.

10. Byun SH, Jeon Y. Administration of vitamin c in a patient with herpes zoster: a case report. Korean J Pain. 2011; 24:108–111. PMID: 21716609.

11. Attal N, Cruccu G, Haanpää M, Hansson P, Jensen TS, Nurmikko T, et al. EFNS Task Force. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol. 2006; 13:1153–1169. PMID: 17038030.

12. Deer T, Ranson M, Kapural L, Diwan SA. Guidelines for the proper use of epidural steroid injections for the chronic pain patient. Tech Reg Anesth Pain Manag. 2009; 13:288–295.

13. Boswell MV, Shah RV, Everett CR, Sehgal N, McKenzie Brown AM, Abdi S, et al. Interventional techniques in the management of chronic spinal pain: evidence-based practice guidelines. Pain Physician. 2005; 8:1–47. PMID: 16850041.

14. Hempenstall K, Nurmikko TJ, Johnson RW, A'Hern RP, Rice AS. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med. 2005; 2:e164. PMID: 16013891.

15. Yeo JS, Sim WS, Kim YC. Herpes sine zoster: is the cause for the segmental intercostal neuralgia of unknown cause?: a case report. Korean J Pain. 2005; 18:226–228.